We are analyzing https://link.springer.com/article/10.1186/s12935-015-0247-4.

Title:
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis | Cancer Cell International
Description:
Tumorigenesis is a multistep process, de-regulated due to the imbalance of oncogenes as well as anti-oncogenes, resulting in disruption of tissue homeostasis. In many cases the effect of oncogenes and anti-oncogenes are mediated by various other molecules such as microRNAs. microRNAs are small non-coding RNAs established to post-transcriptionally regulate more than half of the protein coding genes. miR cluster 143/145 is one such cancer-related microRNA cluster which is down-regulated in most of the cancers and is able to hinder tumorigenesis by targeting tumor-associated genes. The fact that they could sensitize drug-resistant cancer cells by targeting multidrug resistant genes makes them potent tools to target cancer cells. Their low levels precede events which lead to cancer progression and therefore could be considered also as biomarkers to stage the disease. Interestingly, evidence suggests the existence of several in vivo mechanisms by which this cluster is differentially regulated at the molecular level to keep their levels low in cancer. In this review, we summarize the roles of miR cluster 143/145 in cancer, their potential prognostic applications and also their regulation during tumorigenesis.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

pubmed, google, scholar, cancer, article, cas, cells, cell, microrna, cluster, central, expression, mirnas, growth, wang, targeting, human, micrornas, carcinoma, zhang, tumor, inhibits, targets, invasion, mol, res, cancers, target, breast, liu, proliferation, regulate, chen, levels, metastasis, gene, prostate, oncol, tumorigenesis, stem, oncogene, migration, colorectal, genes, factor, regulation, functions, tumors, glioma, regulates,

Topics {✒️}

regulate wnt/beta-catenin signaling tumor-promoting feed-forward pathway lps-induced interferon-gamma van holst-pellekaan ng article download pdf regulates interferon-beta induction rna-induced silencing complex targets estrogen receptor-alpha hpv+ve cervical cancers shorter disease-free survival inhibit tumor-initiating cells pparγ-responsive element present wild-type p53 suppresses mir-145 transfected-hep3b cells exosome-formed synthetic microrna-143 death-promoting regulatory loop microrna-145 post-transcriptionally regulates miapaca-2-xenografted mice induced resistin-induced insulin resistance reduced anchorage-independent growth higher prostate-specific antigen micro-rna genes mir15 il-6-mediated paracrine effects cancer-related microrna cluster acth-secreting pituitary tumors high-throughput micrornaome analysis regulating pi3k/akt pathways p53 represses c-myc mdm2-p53 feedback loop modulates cell growth kent oa computational biology group anti-oncogenic factors mediate mir-145 induces caspase-dependent select estrogen-regulated micrornas multidrug resistant proteins follicle-stimulating hormone regulation papillary thyroid carcinoma hpv-e6 expression estradiol-repressed micrornas lung adenocarcinoma patients suppress invasion-metastasis cascade regulatory rnas present mkn-1 cells resulted villadsen sb growth factor pathway privacy choices/manage cookies small cell carcinoma enhances temozolomide-induced apoptosis renal cell carcinoma

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
         description:Tumorigenesis is a multistep process, de-regulated due to the imbalance of oncogenes as well as anti-oncogenes, resulting in disruption of tissue homeostasis. In many cases the effect of oncogenes and anti-oncogenes are mediated by various other molecules such as microRNAs. microRNAs are small non-coding RNAs established to post-transcriptionally regulate more than half of the protein coding genes. miR cluster 143/145 is one such cancer-related microRNA cluster which is down-regulated in most of the cancers and is able to hinder tumorigenesis by targeting tumor-associated genes. The fact that they could sensitize drug-resistant cancer cells by targeting multidrug resistant genes makes them potent tools to target cancer cells. Their low levels precede events which lead to cancer progression and therefore could be considered also as biomarkers to stage the disease. Interestingly, evidence suggests the existence of several in vivo mechanisms by which this cluster is differentially regulated at the molecular level to keep their levels low in cancer. In this review, we summarize the roles of miR cluster 143/145 in cancer, their potential prognostic applications and also their regulation during tumorigenesis.
         datePublished:2015-09-29T00:00:00Z
         dateModified:2015-09-29T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12935-015-0247-4
         keywords:
            MicroRNAs
            miR cluster 143/145
            Anti-oncomiR
            Multidrug resistance
            Tumorigenesis
            Cancer Research
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-015-0247-4/MediaObjects/12935_2015_247_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-015-0247-4/MediaObjects/12935_2015_247_Fig2_HTML.gif
         isPartOf:
            name:Cancer Cell International
            issn:
               1475-2867
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ani V. Das
               affiliation:
                     name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
                     address:
                        name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Radhakrishna M. Pillai
               affiliation:
                     name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
                     address:
                        name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
      description:Tumorigenesis is a multistep process, de-regulated due to the imbalance of oncogenes as well as anti-oncogenes, resulting in disruption of tissue homeostasis. In many cases the effect of oncogenes and anti-oncogenes are mediated by various other molecules such as microRNAs. microRNAs are small non-coding RNAs established to post-transcriptionally regulate more than half of the protein coding genes. miR cluster 143/145 is one such cancer-related microRNA cluster which is down-regulated in most of the cancers and is able to hinder tumorigenesis by targeting tumor-associated genes. The fact that they could sensitize drug-resistant cancer cells by targeting multidrug resistant genes makes them potent tools to target cancer cells. Their low levels precede events which lead to cancer progression and therefore could be considered also as biomarkers to stage the disease. Interestingly, evidence suggests the existence of several in vivo mechanisms by which this cluster is differentially regulated at the molecular level to keep their levels low in cancer. In this review, we summarize the roles of miR cluster 143/145 in cancer, their potential prognostic applications and also their regulation during tumorigenesis.
      datePublished:2015-09-29T00:00:00Z
      dateModified:2015-09-29T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12935-015-0247-4
      keywords:
         MicroRNAs
         miR cluster 143/145
         Anti-oncomiR
         Multidrug resistance
         Tumorigenesis
         Cancer Research
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-015-0247-4/MediaObjects/12935_2015_247_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-015-0247-4/MediaObjects/12935_2015_247_Fig2_HTML.gif
      isPartOf:
         name:Cancer Cell International
         issn:
            1475-2867
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ani V. Das
            affiliation:
                  name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
                  address:
                     name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Radhakrishna M. Pillai
            affiliation:
                  name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
                  address:
                     name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Cell International
      issn:
         1475-2867
      volumeNumber:15
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
      address:
         name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
         type:PostalAddress
      name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
      address:
         name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ani V. Das
      affiliation:
            name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
            address:
               name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Radhakrishna M. Pillai
      affiliation:
            name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology
            address:
               name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India
      name:Cancer Research Program-9, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram-14, India

External Links {🔗}(576)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Particles.js
Prism.js

CDN Services {📦}

Crossref

5.98s.

LINK . SPRINGER . COM {}